세계의 조직 은행 시장 : 제품, 용도, 최종 사용자별 예측(2025-2030년)

The Tissue Banking Market was valued at USD 33.81 billion in 2023, expected to reach USD 37.13 billion in 2024, and is projected to grow at a CAGR of 9.91%, to USD 65.54 billion by 2030.

The scope and definition of tissue banking encompass the collection, processing, storage, and distribution of human tissues for therapeutic and research purposes. This process is crucial for applications in regenerative medicine, cancer treatment, and transplantation, as well as serving as a vital resource in biomedical research. Tissue banks play an essential role in ensuring the timely availability of tissues that meet quality and safety standards. The end-use scope includes hospitals, research institutes, and biopharmaceutical companies, each utilizing the tissues for their specific applications, ranging from direct patient care to advanced medical research and the development of novel therapies.

Key growth factors influencing the tissue banking market include advancements in biotechnology, increasing demand for regenerative medicine, and the rising prevalence of chronic diseases necessitating advanced therapeutic solutions. Government initiatives promoting tissue-based research and increasing R&D investments by pharmaceutical companies further bolster this growth. Notable opportunities lie in expanding emerging markets, underscored by improving healthcare infrastructure and growing tissue donation awareness. To capitalize, businesses should focus on developing cost-effective and efficient tissue preservation techniques, enhancing the reliability of tissue-engineered products, and forming strategic partnerships with academic and research institutions.

Challenges affecting market growth include stringent regulatory frameworks governing tissue banking operations and ethical concerns related to tissue donation and usage. Technological hurdles in the preservation and long-term storage of tissues also pose significant challenges. Innovations in cryopreservation methods, automation in tissue processing, and development of bio-banking software for data management present promising areas for research and business growth.

The market is characterized by a complex interplay of regulatory and ethical considerations, mixed with rapid technological advancements. Thus, companies must prioritize compliance with regulatory standards while investing in cutting-edge research and development. Collaboration with regulatory bodies, investment in training, and public awareness campaigns about tissue donation are recommended strategies to foster market expansion and address current limitations.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Banking Market

The Tissue Banking Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of bio banks across the globe
  • Government initiatives by healthcare organizations to improvise healthcare facilities
  • Rapid development of transplant medicine and rise in applications of human tissue
• Market Restraints
  • High-cost involved in preservation of biological tissues under controlled environments
• Market Opportunities
  • Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
  • Advancements in biobanking technology in the healthcare sector
• Market Challenges
  • Limitations of tissue banking

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Banking Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Banking Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Banking Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Banking Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Banking Market

A detailed market share analysis in the Tissue Banking Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Banking Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Banking Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Banking Market

A strategic analysis of the Tissue Banking Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Banking Market, highlighting leading vendors and their innovative profiles. These include Beckman Coulter, Inc., Bio-Rad Laboratories Inc., BioKryo GmbH, Bluechiip Limited, Chernobyl Tissue Bank, Corning Incorporated, Eli Lilly & Company, Merck KGaA, Organ Recovery Systems, Inc., Panasonic Corporation, PHC Holdings Corporation, QIAGEN N.V., Sanofi SA, Taylor-Wharton International LLC, Thermo Fisher Scientific Inc., and VIVEX Biologics, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Banking Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Equipment.
• Based on Application, market is studied across Cosmetics, Medical research, and Therapeutics.
• Based on End User, market is studied across Biobanks, Hospitals & Clinics, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of bio banks across the globe
    • 5.1.1.2. Government initiatives by healthcare organizations to improvise healthcare facilities
    • 5.1.1.3. Rapid development of transplant medicine and rise in applications of human tissue
  • 5.1.2. Restraints
    • 5.1.2.1. High-cost involved in preservation of biological tissues under controlled environments
  • 5.1.3. Opportunities
    • 5.1.3.1. Upgradation in the storage of tissues owing to the huge progression in medicinal analysis
    • 5.1.3.2. Advancements in biobanking technology in the healthcare sector
  • 5.1.4. Challenges
    • 5.1.4.1. Limitations of tissue banking
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Tissue Banking Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Equipment

7. Tissue Banking Market, by Application

• 7.1. Introduction
• 7.2. Cosmetics
• 7.3. Medical research
• 7.4. Therapeutics

8. Tissue Banking Market, by End User

• 8.1. Introduction
• 8.2. Biobanks
• 8.3. Hospitals & Clinics
• 8.4. Research & Academic Institutes

9. Americas Tissue Banking Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Tissue Banking Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Banking Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Beckman Coulter, Inc.
• 2. Bio-Rad Laboratories Inc.
• 3. BioKryo GmbH
• 4. Bluechiip Limited
• 5. Chernobyl Tissue Bank
• 6. Corning Incorporated
• 7. Eli Lilly & Company
• 8. Merck KGaA
• 9. Organ Recovery Systems, Inc.
• 10. Panasonic Corporation
• 11. PHC Holdings Corporation
• 12. QIAGEN N.V.
• 13. Sanofi SA
• 14. Taylor-Wharton International LLC
• 15. Thermo Fisher Scientific Inc.
• 16. VIVEX Biologics, Inc.